Invention Grant
- Patent Title: Recombinant cell surface markers
-
Application No.: US17207523Application Date: 2021-03-19
-
Publication No.: US12054531B2Publication Date: 2024-08-06
- Inventor: Howell Franklin Moffett , Marc Joseph Lajoie , Scott Edward Boyken
- Applicant: Lyell Immunopharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: LYELL IMMUNOPHARMA, INC.
- Current Assignee: LYELL IMMUNOPHARMA, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: STEPTOE LLP
- Agent Z. Ying Li; Debashree Chatterjee
- Main IPC: C07K14/71
- IPC: C07K14/71 ; A61K35/17 ; C07K14/535 ; C07K14/705 ; C07K14/725 ; C07K16/28 ; A61K38/00
Abstract:
The present disclosure relates to EGFR-derived polypeptides containing short juxtamembrane sequences, nucleic acids encoding them, and methods of using them to improve cell surface expression of truncated EGFR markers.
Public/Granted literature
- US20210309717A1 Novel Recombinant Cell Surface Markers Public/Granted day:2021-10-07
Information query
